地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：15172431432
传真：13212737804
邮箱：sales@amyjet.com
艾美捷科技代理Monosan品牌。
MONOSAN公司，自1979年生产销售第一个抗大鼠T细胞单克隆抗体以来，一直为生命科学研究领域提供抗体和试剂。产品线包含单克隆抗体、多克隆抗体及试剂，产品系列包括：
（1）MONOSAN® Xtra系列
MONOSAN®Xtra常规MONOSAN®产品线的独特补充。MONOSAN® Xtra系列中的抗体特别适用于冷冻和FFPE组织切片的免疫组织化学(IHC)和免疫荧光(IF)研究。MONOSAN® Xtra单
克隆和多克隆抗体被证明具有优良的品质并显示出高一致性。
（2）MONOSAN®即用型系列
为了减少组织病理学工作流程并消除免疫染色中的不确定性，MONOSAN®设计了一种名为MONOSAN®即用型的预稀释抗体系。该系列包含用于冷冻和FFPE组织切片的免疫组织化学(IHC)
抗体产品。
（3）MONOSAN® 试剂系列
除了常规抗体产品外，MONOSAN®还提供MONOSAN®试剂。该产品线包含用于免疫组化目的的大量检测系统组合，如 MONOSAN® Plus(AP)聚合物试剂盒、MONOSAN® Plus (HRP)
广谱试剂盒和MONOSAN®(HRP)广谱试剂盒。MONOSAN®试剂检测试剂盒设计用于定性检测固定石蜡包埋组织切片、冷冻组织切片和细胞学样品中的抗原。
< " data-original="http://hmgbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Monosan品牌"> 艾美捷科技代理Monosan品牌
日本和光纯药工业株式会社“Wako”系列试剂涵盖了全面的生物化学、分析化学、有机化学、环境分析、食品·医药品分析、高纯度及认证标准品等多类，约50万种试剂。Wako尤以致力于某些当前特殊的高端领域，如：癌症病的研究及有效防治、农兽药残留物分析、中药研究、食品科学和水质分析等关乎人类健康的生命科学研究，并且独树一帜，经历大量成功实验应用案例从而奠定了其在试剂领域中强而有力的地位。
Wako的主要产品包括：
生物化学类
分析化学类
环境分析用试剂
合成用试剂
素材研究用试剂
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://hmgbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Wako"> Wako
艾美捷科技特约代理Aviscera Bioscience全系列产品。
Aviscera Bioscience是一家领先的销售有特色的用于代谢综合症和心血管疾病研究的肌肉因子和细胞因子的供应商。主要产品类别：用于心血管疾病、骨质疏松、肾脏损伤/肾功能衰竭、感染和败血症、代谢综合症、癌症/肿瘤、阿尔茨海默氏症、慢性阻塞性肺病和肺纤维化、哮喘的生物标志物ELISA试剂盒。产品包括很多哺乳动物肌肉因子和细胞因子的ELISA试剂盒及其相应的无标记及标记的抗体和重组蛋白。
Leading Supplier of Specialty Adipokines, Myokines and Cytokines for Metabolic Syndrome & Cardiovascular Diseases Research.
Aviscera Bioscience的主要产品包括：
New Human CTRP15/Myonectin ELISA Kits
New Soluble NRG4 ELISA Kits
New Renin (Total) (Human) ELISA Kits and Proteins
New Stanniocalcin-1 (Human) ELISA Kits
New human CTRP6 ELISA Kit
New Anti Human Soluble ST2 Monoclonal Antibodies for ST2 Immunoassay Development
Anti VGF antibodies validated on WB
IL-17 Receptor A & D ELISA Kits
Stathmin 1/Metabolastin ELISA, Antibody Recombinant
IL-37 ELISA, Antibody Recombinant Proteins
Updated FGF-23 (Human) ELISA Kit
New VEGFR3/FLT-4 (Human) ELISA Kits
Updated Irisin (Human) ELISA Kit
Human Azurocidin/CAP37 ELISA Kit
New Neurotrimin (NTM) rec
cAMP Assay Kit
New HE4/WFDC2/WAP5 ELISA Kit
New IL-18R1, IL-18RAP ELISA Kits
Elafin/PI3/WFDC14 ELISA Kit
Soluble CD112 ELISA for serum or plasma samples
New APOA-IV (Human) ELISA Kit
New Soluble CD305 ELISA Kits
New Soluble Neprilysin (Human) ELISA Kits
New Human SPARC ELISA Kit
New Anti Human Galectin-3 Monoclonal Antibodies for Galectin-3 Immunoassay
New updated mouse serum albumin ELISA Kit
New Soluble CD14 Ultrasensitive ELISA Kits
New Adipsin (Human) ELISA Kit
Updated Irisin (Human) ELISA Kit
Updated Neprilysin /CD10 (Human) ELISA Kit
Updated MPF (Human) ELISA Kit
Soluble Arginase 1 (Human) ELISA Kit
Heart Cadherin / T-Cadherin ELISA Kit
Soluble Neuregulin-4 elisa kit
New Mouse CTRP4 Rec
New irisin elisa kit with HEK293 derived standard and new monoclonal antibodies
Asprosin Monoclonal Antibody
New Active IL-29 (Human) ELISA Kit
Soluble ACVRL1 ELISA Kit
等
" data-original="http://hmgbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Aviscera Bioscience"> Aviscera Bioscience
艾美捷科技特约代理Cosmo Bio公司产品。
Cosmo Bio Co., Ltd.是日本最大、最值得信赖的生命科学研究的产品供应商之一。公司成立于1983年，提供超过36万的产品。其丰富的产品种类、快捷的物流、详尽的产品资料、专业的客户支持和服务，不断的推动着生命科学的发展和进步。
Cosmo Bio provides the most up-to-date products and technical information available from world-class manufacturers, to laboratories, research institutes, life-science education and testing organizations throughout Japan and around the world. We are proud that our ability to supply a vast array of products and information allows us to serve the needs of all of our customers. By making full use of our international network, coupled with the highest quality information, we support the life sciences community with a level of commitment and responsibility befitting a company that is trusted by its valued customers.
主要产品分类：
仪器(Instruments)、细胞融合、转染、培养(Cell Fusion, Transfection, Culture)、体外翻译(In vitro Translation)、抗体(Antibodies)、检测试剂盒(ELISA & Detection Kits ELISA)、生物医学相关(Biomedical)、蛋白质、多肽&糖类(Proteins, Peptides & Sugars)、化学试剂(Chemicals)、分子生物(DNA Molecular Biology)
" data-original="http://hmgbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理Cosmo Bio公司产品"> 艾美捷科技特约代理Cosmo Bio公司产品
Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。
DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.
Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.
The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.
<<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://hmgbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Dendritics"> Dendritics艾美捷科技有限公司代理Kingfisher Biotech公司产品，详见：
http://www.amyjet.com/Index/lists/catid/27/kid/51.html
Kingfisher Biotech致力于兽医学研究和人类疾病的动物模型，涵盖的物种包括：牛、狗、马、鸡、海豚、猫、猪、仓鼠、小鼠、兔子、大鼠、火鸡等等。目前，Kingfisher Biotech的产品线中有查过1200种重组蛋白、多抗、单抗和ELISA试剂盒，能够为全世界动物保健和动物模型客户提供优质的产品。
Kingfisher Biotech, Inc. is committed to accelerating basic veterinary research and human disease research done in animal models by developing and commercializing research reagents specific for a variety of species, including bovine, canine, caprine, chicken, dolphin, equine, feline, guinea pig, hamster, human, mouse, ovine, rabbit, rat, swine, and turkey. We will continue to add species as our customer request specific reagents for their research. Currently, we offer over 1200 recombinant proteins, polyclonal antibodies, monoclonal antibodies and ELISA kits for animal health and animal model research. Our products are primarily cytokines, chemokines, interferons, and growth factors.
Kingfisher Biotech公司产品涉及的物种包括：
Bovine、Canine、Caprine、Catfish、Chicken、Dolphin、Equine、Feline、Ferret、Guinea Pig、Hamster、Human、Llama、Monkey、Mouse、Ovine、Rabbit、Rat、Salmon、Swine、Turkey、Zebrafish
| 产品列表 |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1675A-025) |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1675A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1676A-100) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1676A-025) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1676A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1676A-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| Cynomolgus Monkey CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1692Y-003) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1644AP-025) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1644AP-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 alpha (IL-1F1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0667B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Human APRIL (TNFSF13) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0292H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1085H-100) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1085H-025) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1085H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1085H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human CCL21 (6Ckine) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1512H-005) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1531H-025) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1531H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1657GP-100) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1657GP-025) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1657GP-005) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1657GP-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0754D-100) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0754D-025) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0754D-005) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0754D-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0085D-100) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0085D-025) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0085D-005) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0085D-500) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0920D-100) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0920D-025) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0920D-005) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0920D-500) |
| Canine IL-25 (IL-17E) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1697D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Catfish IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0439CF-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Llama ACT1 Activation Monoclonal Antibody (clone LH9A) (Kingfisher, CAT#WS0813L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LH7A) (Kingfisher, CAT#WS0812L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LT78A) (Kingfisher, CAT#WS0823L-100) |
| Llama CD2 or CD6 predicted Monoclonal Antibody (clone LH43A) (Kingfisher, CAT#WS0815L-100) |
| Llama CD2 or CD6 Predicted Monoclonal Antibody (clone LT10A) (Kingfisher, CAT#WS0819L-100) |
| Llama CD44 Monoclonal Antibody (clone LT36A) (Kingfisher, CAT#WS0821L-100) |
| Llama CD45 Predicted Monoclonal Antibody (clone LT12A) (Kingfisher, CAT#WS0820L-100) |
| Llama CD5 Predicted Monoclonal Antibody (clone LT3A) (Kingfisher, CAT#WS0817L-100) |
| Llama CD8 Monoclonal Antibody (clone LT5A) (Kingfisher, CAT#WS0818L-100) |
| Llama MHC II Monoclonal Antibody (clone LT1A) (Kingfisher, CAT#WS0816L-100) |
| Llama Pan B cell Monoclonal Antibody (clone LH41A) (Kingfisher, CAT#WS0814L-100) |
| Llama Pan T cell Monoclonal Antibody (clone LT97A) (Kingfisher, CAT#WS0824L-100) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1031Y-100) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1031Y-025) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1031Y-005) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1031Y-500) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1321Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1321Y-025) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1321Y-005) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1321Y-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody (Kingfisher, CAT#KP1669Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1670Y-050) |
| Cynomolgus Monkey IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1671Y-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody (Kingfisher, CAT#KP1694D-100) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1695D-050) |
| Canine BAFF (TNFSF13B) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1696D-003) |
| Canine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0891D-003) |
| Canine Fas Ligand (FasL) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1288D-003) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1647CT-100) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1647CT-025) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1647CT-005) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1647CT-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0665B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Bovine TNF alpha (TNFSF2) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0675B-003) |
| Bovine VEGF-A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0676B-003) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL2 (MCP-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0659B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0003E-100) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0003E-025) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0003E-005) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0003E-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Zebra Finch SCF (Stem Cell Factor) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1579ZN-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0013B-100) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0013B-025) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0013B-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0013B-500) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0311B-100) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0311B-025) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0311B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0311B-500) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.
Berry & Associates的主要产品包括：
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://hmgbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸
KAMIYA公司旨在为生命科学和医疗机构提供高品质的创新的实验室研究和诊断工具。KAMIYA公司最早研发的产品是最前沿的用于信号转导研究的蛋白激酶抑制剂staurosporine（星形孢菌素）和K252a。1990年，KAMIYA成为美国第一家生产细胞凋亡研究的anti-Fas单克隆抗体的公司。如今，KAMIYA的产品线包括数千种人和动物临床前试验的生物标志物检测试试剂盒。此外,KAMIYA公司还为生命科学领域的研究着提供多种多样的酶抑制剂、单克隆抗体和多克隆抗体等产品，可用于研究细胞凋亡、耐药性、氧化、DNA损伤和修复、骨骼生物学、癌症、心脏病、炎症、肥胖症、糖尿病等研究。
KAMIYA公司K-ASSAY产品，用于胰岛素、血浆D-二聚体、凝血因子xiii、血浆FDP、血清/尿液 FPD、血清/尿液FDP-E、总IgE等指标的检测。KAMIYA现已发展成美国最大的脂质血清蛋白免疫分析试剂生厂商，为众多大型医院、医疗中心、临床实验室、临床参考实验室、科研机构、诊断试剂研发公司等机构提供优质的临床诊断试剂。
KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California and relocated to Seattle, Washington in 1996. Our company's purpose is supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality. KAMIYA is an independent American company that serves worldwide markets.
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
< " data-original="http://hmgbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Kamiya Biomedical"> Kamiya Biomedical
作为全球血栓与止血诊断领域的领导者，Stago公司的使命是为实验室人员及临床医生提供可靠准确的血栓与止血疾病诊断工具，从而更有效地认知、治疗和监测相关疾病，改善患者生活。
From Research & Development and Production to Logistics, Marketing, Sales and International Distribution, Stago remains in control of its strategy at all levels. Certified ISO 13485, ISO 9001 (2008) and ISO 14001 for its main reagent manufacturing plant. the group’s industrial activities are mostly concentrated in France. Its geographical expansion has led to opening R&D and production centers in the USA, Netherlands, Germany, Ireland and China.
Ever since our American subsidiary was established in 1985, our distribution network grew considerably throughout the world. Since 2003, 17 new affiliates have been opened: China (2003), United Kingdom (2005), Dubai (2007), Australia/New Zealand and Canada (2008), Hong-Kong (2011), Germany, Austria, Spain, Italy, Portugal, Switzerland, Belgium, Netherlands (all opened in 2012), India (2014), Brazil (2016) and Turkey (2017).
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://hmgbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Stago"> Stago
RNAssist专注于单细胞分析中生物大分子的稳定剂研发，其专利性的产品在保障RNA和生物分子稳定性的同时，还可以有效保存细胞形态，和使病毒/细菌失活。三个系列的产品，包括vivoPHIX™, genoPHIX™和virusPHIX™，他们都能够对临床样本提供有效保护和灭活病原体，同时各自又有不同的功效，适用于细胞&组织固定、ISH、IF、scRNA-seq、二代测序等领域。
<【vivoPHIX】
vivoPHIX™ 单细胞组学专用组织RNA稳定剂，10ml
vivoPHIX™ (10ml) – RNA stabilisation solution for single cell analysis
货号：RD-VIVO-10
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂，20ml
vivoPHIX™ (20ml) – RNA stabilisation solution for single cell analysis
货号：RD-VIVO-20
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂，30ml
vivoPHIX™ (30ml) – RNA stabilisation solution for single cell analysis
货号：RD-VIVO-30
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂，50ml
vivoPHIX™ (50ml) – RNA stabilisation solution for single cell analysis
货号：RD-VIVO-50
vivoPHIX™单细胞组学专用组织RNA稳定剂，可以用于组织中RNA的固定保存，特别适合后续多组学检测，包括scRNA-seq试验和SMART-seq试验。其发挥的作用包括：生物分子的稳定（RNA、DNA和磷酸化蛋白）、细胞固定、组织分离和病毒/细菌灭活。
<【genoPHIX】
genoPHIX™ 全组分组织稳定剂，20ml
genoPHIX™ 20ml: For projects involving large tissue samples
货号：RD-GENO-20
<genoPHIX™ 全组分组织稳定剂，50ml
genoPHIX™ 50ml: For projects involving large tissue samples
货号：RD-GENO-50
genoPHIX™ 全组分组织稳定剂，适合应用于石蜡包埋组织样品。其独特的性质，使得这个试剂可以从石蜡包埋组织中提取核酸并保持其稳定性，是IHC、IF、FISH、荧光蛋白检测的理想选择。
【virusPHIX】
<virusPHIX™ – RNA Stabiliser and virus inactivation reagent
virusPHIX™ RNA稳定及病毒灭活试剂
货号：N/A
（1）稳定组织样品中的RNA、DNA和磷酸化蛋白；
（2）对组织样品中病毒、细菌、酵母进行有效灭活，提高生物安全性；
（3）适合分子测试；
（4）可与多种RNA提取试剂盒配合使用，包括：RNeasy™, QIAamp™, QIAsymphony™, QIAcube™, Nuclisens™, GeneXpert™and Filmarray™
（5）无毒、稳定、常温运输。
< " data-original="http://hmgbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="RNAssist系列稳定剂（virusPHIX™、genoPHIX™、vivoPHIX™）"> RNAssist系列稳定剂（virusPHIX™、genoPHIX™、vivoPHIX™）地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18995651644
传真：18771997407
邮箱：sales@amyjet.com
0.3026
